Half-year report · Q2
7747.TEDINET S100V8NQ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥107.5bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.3bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.0bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.4bn | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.8bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.8bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥9.9bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥191.6bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥169.1bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥152.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥138.8bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥37.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.6bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21.2bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.8bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.2 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.15 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥3.4bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥12.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥6.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥14.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥61.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥16.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 23084032 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0849 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 22173800 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0816 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 10164100 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0374 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 8022929 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0295 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 7200000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0265 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 6594292 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0242 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 6560638 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0241 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 5878600 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0216 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 5819200 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0214 | |
| Number of shares held | CurrentQuarterInstant | 134865591 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4965 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 271595700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2715957 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 30000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 271633600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 2715957 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 7900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 7900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 7900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 35658000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 37564000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 17676000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 16561000000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 1913000000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 2018000000 | JPY |
| Short term investment securities | Prior1YearInstant | 3000000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 3999000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 9282000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 8539000000 | JPY |
| Work in process | Prior1YearInstant | 12298000000 | JPY |
| Work in process | CurrentQuarterInstant | 11333000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |